In a bold move, President Trump has signed an executive order to slash drug prices in the U.S., aligning them with the lowest prices globally. This 'nation most favored' pricing strategy could revolutionize the pharmaceutical landscape,

Trump wanted to advance the ‘most favored nation’ policy in his first term but faced resistance from industry and the courts.

President Donald Trump signed a groundbreaking executive order directing pharmaceutical companies to reduce drug prices in the United States. The order mandates that prices align with those paid by other countries,